Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Onychomycosis

In brief

A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical product in Patients with Mild to Moderate Onychomycosis

Key facts

Study ID

NCT02933879

Run by

Sun Pharmaceutical Industries, Inc.

People needed

184

Starts

2016-03-21

Expected to finish

2018-06-21

Last updated by the study team

2018-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of onychomycosis of the target toenail (defined as one of the infected great toenails).

You may not qualify if…

• Females who are pregnant, lactating or likely to become pregnant during the study.

Where it is running

• Novum Pharmaceutical Research Services (Novum) — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.